Comparative Pharmacology
Head-to-head clinical analysis: COACTIN versus KERLEDEX.
Peer-Reviewed Evidence
Head-to-head clinical analysis: COACTIN versus KERLEDEX.
COACTIN vs KERLEDEX
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Coactin (mecillinam) is a beta-lactam antibiotic that inhibits bacterial cell wall synthesis by binding to penicillin-binding protein 2 (PBP2) in gram-negative bacteria, leading to the formation of spheroplasts and cell lysis.
Kerledex is a selective serotonin reuptake inhibitor (SSRI) that potentiates serotonergic activity in the CNS by inhibiting the reuptake of serotonin at the presynaptic neuronal membrane.
400 mg orally every 6-8 hours with a full glass of water.
Intravenous: 500 mg every 6 hours; Oral: 250 mg every 8 hours.
None Documented
None Documented
Terminal elimination half-life: 1.0-1.5 hours in adults with normal renal function; prolonged to 2-6 hours in renal impairment; clinically requires frequent dosing or dose adjustment in renal failure.
Terminal half-life 12 hours (range 10–14) in normal renal function; extended to 30–50 hours in severe renal impairment (CrCl <30 mL/min); 6–8 hours in hepatic cirrhosis.
Renal: approximately 70-80% as unchanged drug via glomerular filtration and tubular secretion; biliary/fecal: less than 10% as metabolites and unchanged drug.
Renal: 70% unchanged; fecal/biliary: 20% as metabolites; 10% as minor metabolites. Total renal clearance 180 mL/min, active tubular secretion accounts for 60% of renal elimination.
Category C
Category C
Antibiotic Combination
Corticosteroid/Antibiotic Combination